VALSALVA RETINOPATHY: Clinical Features and Treatment Outcomes.
Retina
; 43(8): 1317-1320, 2023 08 01.
Article
in En
| MEDLINE
| ID: mdl-36893442
ABSTRACT
PURPOSE:
To report the clinical presentation and outcomes in patients with Valsalva retinopathy.METHODS:
This was a retrospective case series of patients diagnosed with Valsalva retinopathy between June 1, 2010, and May 31, 2020. Clinical notes, operative reports, fundus photography, and optical coherence tomography images were reviewed.RESULTS:
This study comprised 58 eyes of 58 patients. The most common causes were lifting (34.4%), vomiting (20.6%), straining (20.6%), and coughing (17.2%). Mean best-corrected visual acuity at diagnosis was 20/163. The most frequently involved vitreoretinal compartment was the subhyaloid space (42.3%) followed by the intraretinal (32.7%), intravitreal (23.1%), and subretinal (13.4%) spaces. Mean best-corrected visual acuity of all patients was 20/59 at 3 months, 20/48 at 6 months, and 20/22 at 1 year. Mean time to clearance of hemorrhage on clinical examination was 99.0 ± 18.7 days in patients who underwent observation and 4.5 ± 3.5 days after surgery in patients who received pars plana vitrectomy.CONCLUSION:
Valsalva retinopathy is generally associated with a favorable visual prognosis. Most eyes perform well with observation although pars plana vitrectomy may be indicated in patients requiring rapid resolution of hemorrhage.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retinal Hemorrhage
/
Diabetic Retinopathy
Limits:
Humans
Language:
En
Journal:
Retina
Year:
2023
Document type:
Article
Publication country:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA